Tamsulosin 0.4 mg prolonged-release tablets (test formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tamsulosin 0.4 mg prolonged-release tablets (test formulation), covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions [Phase 1]